Anlon Healthcare Limited (NSE:AHCL)

Market Cap	10.40B +83.5%
Revenue (ttm)	2.26B +95.4%
Net Income	316.29M +55.8%
EPS	0.76
Shares Out	531.52M
PE Ratio	25.76
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	150,744,012
Open	17.73
Previous Close	17.54
Day's Range	17.54 - 20.00
52-Week Range	10.20 - 19.57
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About Anlon Healthcare

Anlon Healthcare Limited manufactures and sells active pharmaceutical ingredients in India and internationally. The company also offers bulk drugs; advanced pharmaceutical intermediates; nutraceutical API products; and drug intermediates. It also manufactures loxoprofen sodium dihydrate, ketoprofen, and dexketoprofen trometamol products for pain management and anti-inflammatory therapies. Anlon Healthcare Limited was incorporated in 2013 and is based in Rajkot, India.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2013
• Employees: 119
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AHCL

Financial Performance

In fiscal year 2026, Anlon Healthcare's revenue was 1.72 billion, an increase of 42.95% compared to the previous year's 1.20 billion. Earnings were 285.14 million, an increase of 38.97%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Sep 11, 2026

Data Sources Report a data error